Fig. 2. Antimicrobial activity of T-CAgNPs against Bap-MRSA 090 and E. coli. The Bap-MRSA 090 evaluated for biocidal activity by T-CAgNPs is shown in a dose-dependent manner (10 to 100 μg mL^–1) compared to antibiotics ciprofloxcin and bacitracin. The minimum inhibitory concentration (MIC) 100 μg mL^–1 of T-C@AgNPs was 10.08 ± 0.06 mm against Bap-MRSA 090 along with standard ciprofloxcin (10.95 ± 0.08) and bacitracin (9.12 ± 0.13) as an antibiotic, respectively (A and B). The T-C@AgNPs showed excellent activity to E. coli at MIC and had 9.16 ± 0.06 mm compared to ciprofloxcin (10 μg = 11.18 ± 0.04 mm) and E. coli resistant to bacitracin can be observed clearly in figure C and D. Whereas blank water served as a negative control depicted in the picture (A and C).